Wyeth Google Group

BEST TRADING ALERTS - MAKES 300% WEEKLY RETURN HIGHLY RECOMMENDED

roberta.oxf...@gmail.com (Roberta Oxford) — Mon, 23 Nov 2009 14:49:20 UT

BEST TRADING ALERTS - MAKES 300% WEEKLY RETURN HIGHLY RECOMMENDED
[link]

TURNED $1,000 INTO OVER $2 MILLION IN JUST A FEW MONTHS.. TRY IT

myrilla.pink...@gmail.com (Myrilla Pinkett) — Thu, 19 Nov 2009 15:18:24 UT

Turn Your $1,000 Into Over 2 Million Dollars With Their Help at
[link]

EXCELLENT TRADING ALERTS - TURNED $1000 INTO 2 MILLION !!! HIGHLY RECOMMENDED !!

adelheid.benja...@gmail.com (Adelheid Benjamin) — Sat, 14 Nov 2009 21:29:35 UT

Turn Your $1,000 Into Over 2 Million Dollars With Their Help at
[link]

Wyeth and Merck May See Increased Orders for their Pneumonia Vaccines this Flu Season

drplum...@gmail.com (Public Health) — Fri, 09 Oct 2009 14:40:24 UT

A significant amount of the hospitalizations and deaths associated
with an initial influenza infections are due to secondary pneumonias
that develop during the course or an individual attempting to fight
the flu. One way to protect against a common cause of secondary
pneumonia, Streptococcus pneumoniae is with a the PPSV23 a pneumonia

Timeline for the merger

audio...@gmail.com — Mon, 08 Jun 2009 11:50:35 UT

Does anybody know where one can get updates on the merger?

Re: king pharma seeing unusual call buying

dp...@embarqmail.com — Fri, 17 Apr 2009 11:11:47 UT

Celgene PEG (price/earnings/Growth rate 5yr) Best in Bio Pharma
PEG= .6 !! Best Industry =~1
Most other big names at 1-3 PEG
CELGENE is best Biopharma Growth and potential upside / MA
The short term target By Morgan Stanley is $60
18 Brokers range $65 median target $78 high
12 STRONG BUYS 3 BUYS 2 HOLD

Wyeth, buy or sell??

eherna2...@gmail.com (Jose H) — Wed, 04 Mar 2009 20:41:59 UT

bough some wyeth back when the pfizer announced its purchased at 43,
but now I'm considering selling it, I don't see any movement in this
stock (except down), any recommendations?

IF YOUR LOOKING FOR A GOOD SPEC PLAY

semperfi...@sbcglobal.net — Sun, 01 Mar 2009 03:21:02 UT

THERE ARE FEW PLAYS YOU CAN MAKE AT THIS TIME LIKE THIS ONE.
CHECK OUT THE ANYALST RATINGS FOR YOURSELF.YES, I AM PUMPING THE
STOCK ,BUT LOOK AND DECIDE FOR YOURSELF. THERE IS MONEY TO BE MADE.

PLEASE SEE BELOW. IT'S EVEN CHEAPER TO BUY NOW.

February 26, 2009 10:39 AM EST
Analysts at Merriman Curhan Ford are out with a positive note on stem

WYE is a strong BUY Pfizer wants the company because it knows there is massive upside

audio...@gmail.com — Thu, 19 Feb 2009 13:48:35 UT

WYE is a strong BUY Pfizer wants the company because it knows there is
massive upside

I was talking to a buddy of mine who works for Pfizer and he told me
the reason for Pfizer's upcoming purchase of Wyeth is because of the
very promising new drug pipeline.

Stimulus Bill. Is it good or a disaster?

optionsman...@gmail.com — Sat, 07 Feb 2009 19:33:36 UT

Do you guys think this bill is actually going to work? I think it will
work for a short term as all stimulus packages do, but definitely not
in the long run! I just posted a blog which is my opinion on this
bill, and invite you to read it. I would like to hear what you think
of my opinion or the bill in general. Please don't mark this as spam

Market shrugged off the bad news. Is the rally for real?

optionsman...@gmail.com — Fri, 06 Feb 2009 23:46:58 UT

Today was a big surprise that we finished higher. I take shrugging off
this negative news to be a very good sign. I checked out the most
traded options today and I have to say they are for the most part very
bullish. I have been tracking the most traded options over the last
few days in my blog if you are interested email me.

Today's option activity was certainly bullish

optionsman...@gmail.com — Fri, 06 Feb 2009 06:58:15 UT

I was doing some research today and realized that there was unusual
amount of call contracts for financial stocks and etfs. I have a
complete list of the top 10 in order posted on my blog for the last 3
days. This is not a spam thread.

The options market has successfully predicted the direction of the

Re: figures...

hde...@gmail.com — Thu, 29 Jan 2009 18:17:42 UT

Was the class any good?

why is this down when whole world is up?

hellomailme...@gmail.com — Wed, 28 Jan 2009 20:39:37 UT

why is this down when whole world is up?

Any room left for this to go up???

jgabaseb...@yahoo.com — Mon, 26 Jan 2009 23:41:10 UT

Is there any more room for this thing to go up or have we seen the pop
and now the slow decline that has accompanied the last few takeover
bids?

What's next?

gchau...@gmail.com (Chauhan) — Mon, 26 Jan 2009 15:29:06 UT

So what's next? When would the transaction happen?

Wyeth- Major Gains and Losses

primetradingsys...@gmail.com — Sun, 25 Jan 2009 05:49:10 UT

Wyeth is making money some days, and other days it is losing money.

So it can be a good pick depending on your methodology.

My firm deals with a computer software system that automatically buys
and sells stock indices and commodities. So it makes money when the
stock market is going up, down, or sideways. It uses successful

Obama administration is going to boost US pharmaceuticals

audio...@gmail.com — Sat, 24 Jan 2009 01:05:46 UT

Obama administration is going to boost US pharmaceuticals

A friend of mine works for GSK (Glaxo), a UK-based pharma firm. He
said that his company (and other non-US pharmaceutical companies) had
enormous difficulties from the Tom Daschle who strongly favors US
pharmaceutical companies.

There is an enormous opportunity to take advantage of this political

crucell

r.pardovi...@gmail.com — Fri, 23 Jan 2009 19:25:51 UT

what do you think will happen in regards to the talks with crucell?

Price per share

jgabaseb...@yahoo.com — Fri, 23 Jan 2009 17:16:25 UT

Any idea what price Pfizer would pay per share for Wyeth

Source for profitable trade

nabosswho...@gmail.com — Fri, 23 Jan 2009 17:16:23 UT

Hello everyone, I have been considering a trade on the penny stocks
known as stocktipusa. Here you would be able to know some good sources
to help to take on a profitable trade. You may have a look at
stocktipusa

35-40% upside expected

audio...@gmail.com — Fri, 23 Jan 2009 13:02:04 UT

35-40% upside expected due to Wyeth's impressive pipeline, biotech
research and fantastic consumer product line. Wyeth has a strong
presence in Asia which will lead to massive growth going forward.

Massive research pipeline + biotech investment=huge upside

audio...@gmail.com — Thu, 08 Jan 2009 14:59:11 UT

Massive research pipeline + biotech investment=huge upside

Wyeth made the mistake of allowing some of its hits become generics
but has learned its lesson and will not do that again.

The company has one of the most impressive R&D pipelines in the
sector.

All this and a fantastic dividend yield to boot.

WYE poised to make great gains from new administration

audio...@gmail.com (Robert) — Mon, 24 Nov 2008 10:51:12 UT

Non-US pharmaceutical plays to suffer from new administration

I was just talking to a friend of mine who works for GSX and he told
me that one Obama's recent appointments is strongly opposed to non-US
pharmaceuticals. He said that US pharmaceutical plays stand to make
great gains at the expense of foreign rivals.

Re: Hi there! I just stumbled across this opportunity where you can make $130 for each person you sign up, $10 for each person that person signs up for you, and $5 for every person that person signs up for you!!! Take advantage of this great opportunity while you can! Make money online now: http://www.lwsfreedom.com/id/greentitan

tinker2evers2cha...@gmail.com — Wed, 26 Nov 2008 20:22:14 UT

spam spam spam spam spam! sssapm sssapm.

Merril Lynch Oct 28 Report Rates WYE a BUY with a $45 price objective

audio...@gmail.com (Robert) — Mon, 03 Nov 2008 06:26:56 UT

Merril Lynch Oct 28 Report Rates WYE a BUY with a $45 price objective

Re: Tired of losing in this shaky market?

ric...@gmail.com (RiceWD) — Tue, 04 Nov 2008 17:08:16 UT

Spam reported

July 24 Merril Lynch Report - Estimates raised

audio...@gmail.com (Robert) — Thu, 24 Jul 2008 08:56:03 UT

July 24 Merril Lynch Report - Estimates raised

Wyeth beats analysts' expectations- the street begins to revise up

audio...@gmail.com (Robert) — Wed, 23 Jul 2008 23:09:25 UT

Wyeth beats analysts' expectations- the street begins to revise up

Goldman Sachs reported in a July 23 research note that more than 50%
of Wyeth's revenues are from international sources.

I expect to see this company continue to improve going forward.
Wyeth's products are very popular in Asian markets and that is where

More foreign acquistions of US bio/pharma companies on the horizon

audio...@gmail.com (Robert) — Tue, 22 Jul 2008 13:24:08 UT

More foreign acquistions of US bio/pharma companies on the horizon

The weakness of the US dollar coupled with cash-rich Asian countries,
European nations with an overvalued currency and oil-money flush Arab
nations is giving foreign concerns a bargain-basement shopping mall in
US assets. Just look at the recent buyout attempt of Genentech.

WYE should see greater upside as Teva has not placed any additional generic Protonix into the supply channel

audio...@gmail.com (Robert) — Mon, 21 Jul 2008 02:32:58 UT

WYE should see greater upside as Teva has not placed any additional
generic Protonix into the supply channel

Superb-lawsuit dismissals to continue

audio...@gmail.com (Robert) — Tue, 15 Jul 2008 13:58:33 UT

The series of dismissals over lawsuits filed against WYE have set a
precent which will continue going forward.

Socialized Medicine. Why?

jacknorm...@hotmail.com (jacksilver00) — Wed, 09 Jul 2008 17:56:29 UT

I have had a taste of "socialized medicine", it is the Kaiser
Permanente Medical Plan. I wanted to have a Dermatologist take a
quick
look at a spot on my cheek. For this I need a referal from my regular
doctor. Trying to make an appointment with him, I heard about 28
recorded messages, most repeating the earlier message. When finally

Morgan Stanley Research Just Upped Wyeth' Price Target -- June 23

audio...@gmail.com (Robert) — Wed, 25 Jun 2008 13:55:16 UT

Morgan Stanley Research Just Upped Wyeth' Price Target -- June 23

Wyeth to post more good news going forward

audio...@gmail.com (Robert) — Thu, 19 Jun 2008 01:28:58 UT

The stock is severely undervalued due to some small bumps over the
last year.

The company has strong R&D and what's more, it has a superb consumer
product line with many products which enjoy strong brand recognition
(and growth) in Asia.

Vindication

safesur...@gmail.com — Wed, 18 Jun 2008 16:50:11 UT

Congrats to all longs! Go WYE and PDGT! God bless us, every one!

ROBERT CHECK OUT FAST MONEY YOUR STOCK IS GOING TO ANOTHER GALAXY

bob12...@comcast.net (BUZZARDBOYLE) — Tue, 08 Apr 2008 00:36:55 UT

May 21, 2007, 8:48 am
Elan and Wyeth Move Ahead on Alzheimer's Drug
Posted by Jacob Goldstein
Elan and Wyeth will move into late-stage testing of an experimental
Alzheimer's drug later this year, the companies said today. The news
drove stock in Dublin-based Elan up more than 10% in London today.

Here goes the momentum

audio...@gmail.com (Robert) — Tue, 08 Apr 2008 00:10:12 UT

Wyeth is getting ready to take off.

7% rise in 24 hours-- Whew!

Significant upside

audio...@gmail.com (Robert) — Tue, 04 Mar 2008 23:45:02 UT

Word on the street is that Wyeth has some more great news coming.

WYETH STILL ON STRONG BUY LIST

jettlay...@hotmail.com — Tue, 04 Mar 2008 12:52:10 UT

WYETH STII ON STRONG BUY LIST,GIVEN ITS NEW DRUG APPROVALS AND
FUNDAMENTALS

Wyeth Rises on Upgrade to 'Strong Buy'

audio...@gmail.com (Robert) — Wed, 13 Feb 2008 23:17:40 UT

AP
Wyeth Rises on Upgrade to 'Strong Buy'
Wednesday February 13, 2:22 pm ET

I think there is going to be more good news going forward.

[link]

HSBC Jan 14 report Reiterates Overweight on Wyeth

audio...@gmail.com (Robert) — Mon, 14 Jan 2008 07:28:00 UT

HSBC Jan 14 report Reiterates Overweight on Wyeth

Merrill Lynch upgrades Wyeth to BUY on Alzheimer's opportunity (11/12)

audio...@gmail.com (Robert) — Mon, 19 Nov 2007 04:16:21 UT

Merrill Lynch upgrades Wyeth to BUY on Alzheimer's opportunity (11/12)

Oil going through the roof. Time to park the cash in safe harbors.

audio...@gmail.com (Robert) — Thu, 01 Nov 2007 00:09:07 UT

Oil going through the roof. Time to park the cash in safe harbors.

Pharmaceuticals are safe harbor during uncertain economic times --- Fortune Magazine

audio...@gmail.com (Robert) — Thu, 11 Oct 2007 23:27:16 UT

Pharmaceuticals are safe harbor during uncertain economic times ---
Fortune Magazine
With the subprime mess and weak employment figures pharmaceuticals are
a safe harbor. They depend more on the introduction of new drugs
instead of economic cycles.

Wyeth, boosts dividend, share buyback $5B

nwadwal...@gmail.com — Thu, 27 Sep 2007 19:43:12 UT

Buy Wyeth and get rich

The Street Rates WYE a BUY Gross profit margin a staggering 73.70%

audio...@gmail.com (Robert) — Thu, 13 Sep 2007 00:02:29 UT

The Street Rates WYE a BUY
They cite the fact that Wyeth's revenue growth has outpaced the
industry average of 8.7%. Revenues have increased 9.5% on a QoQ basis.
Growth has trickled down to the bottom line, boosting EPS.
Earnings have improved by 11.5% QoQ. The company has a pattern of
positive earnings growth over the past couple of years.

August US prescription market growth + 2.5% ----- Sept 12 UBS Report

audio...@gmail.com (Robert) — Wed, 12 Sep 2007 23:37:35 UT

August US prescription market growth + 2.5% ----- Sept 12 UBS Report

Four Wyeth Researchers Honored by American Chemical Society for Pioneering Contributions to Medicinal Chemistry

audio...@gmail.com (Robert) — Fri, 07 Sep 2007 06:34:58 UT

The company is is solid and making progress on the next big thing.
Four Wyeth Researchers Honored by American Chemical Society for
Pioneering Contributions to Medicinal Chemistry

Buy low! Sell high! Great company at a fantastic price.

audio...@gmail.com (Robert) — Wed, 05 Sep 2007 01:36:37 UT

Buy low sell high! Great company at a fantastic price.
Excerpt from a 9/1 article in the Motley Fool.
A quick check of the market's sale rack finds the following:
The likes of UBS (NYSE: UBS), Wyeth (NYSE: WYE) and Sony (NYSE:
SNE), meanwhile, sport stock prices that are at least 20% below their
52-week highs.